Home | Articles
Published on:September 2022
Indian Journal of Pharmaceutical Education and Research, 2022; 56(4):1013-1024
Original Article | doi:10.5530/ijper.56.4.182

Quality by Design: Optimization of Letrozole Solid Lipid Nanoparticle for Breast Cancer

Authors and affiliation (s):

Sowmya Priyadarsini*, Swaroop Rameshwarji Lahoti

Department of Pharmaceutics, Y. B Chavan College of Pharmacy, Dr. Rafiq Zakaria Campus, Rauza bagh, Aurangabad, Maharashtra, INDIA.


Aim: Hormone responsive breast cancer is the most prevalent cancer worldwide. Letrozole is a third-generation aromatase inhibitor widely used for the treatment of advanced breast cancer. The primary objective of the present work is to develop and optimize an injectable solid lipid nanoparticle incorporating letrozole to circumvent the side-effects of a marketed conventional formulation and thereby improve patient compliance. Materials and Methods: Emulsification solvent evaporation and melt dispersion techniques were used for formulating the said solid lipid nanoparticles. Quality by design concept was used for the development and optimization of formulation and process variables. Results: The optimum level selected is 60 mg lipid, 30 mg surfactant, and co-surfactant, 15000 psi HPH pressure, and 15 HPH passes. Conclusion: Glyceryl dibehenate was selected as suitable lipid based on solubility and partition coefficient. With an increase in lipid content there is increase in particle size and PDI and decrease in entrapment efficiency. Higher surfactant and co-surfactant concentrations result in lower particle size, PDI, higher zeta potential, and lower entrapment efficiency. An increase in HPH pressure reduced particle size and PDI up to a certain level, however, the increase in HPH pressure from 15000 to 20000 psi increased particle size. An increase in the number of HPH passes reduces particle size and PDI. The drug release mechanism for LTR-SLN was found to follow the first order and higuichi model.

Keywords: Solid lipid nanoparticle, Letrozole, Ishikawa diagram, Plackett burman design, Central composite design, Mathematical modeling.



Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).


Impact Factor® as reported in the 2021 Journal Citation Reports® (Clarivate Analytics, 2022): 0.843

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.


IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs